Identifying the molecular mechanisms of GEMIN5 mutations in a novel cerebellar ataxia syndrome

鉴定新型小脑共济失调综合征中 GEMIN5 突变的分子机制

基本信息

  • 批准号:
    10753403
  • 负责人:
  • 金额:
    $ 53.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-15 至 2028-06-30
  • 项目状态:
    未结题

项目摘要

Abstract GEMIN5, an RNA-binding protein, is essential for assembly of the Survival Motor Neuron (SMN) complex. GEMIN5 facilitates the formation of small nuclear ribonucleoproteins (snRNPs; the building blocks of spliceosomes). We identified novel autosomal recessive variants in the GEMIN5 gene in multiple patients presenting with motor dysfunction, ataxia, and cerebellar atrophy. Our proposed studies are aimed to understand the molecular mechanisms of mutant GEMIN5 responsible for causing the neurological abnormalities in our patients. We found that patient a significant decrease in GEMIN5 protein levels and reduced protein stability in patient iPSC neurons suggesting a possible loss of function mechanism. Our in vitro assembly assay showed that GEMIN5 variants perturb snRNP assembly formation. To understand the consequences of loss of function GEMIN5, we knockdown endogenous rigor mortis, the Drosophila homologue of human GEMIN5, in Drosophila. Knockdown of rigor mortis (rig) caused motor dysfunction, reduced life span and developmental delay. Interestingly, we observed that CoQ10 levels were significantly reduced in human patient cells and our drosophila model. Treatment with CoQ10 reduced the disease course in human GEMIN5 patients. We generated a mouse model of Gemin5 using CRISPR/cas9 and found early lethality in mice. Our proposed studies are aimed to understand the molecular mechanisms of GEMIN5 by 1) conducting functional analysis of mutant GEMIN5 patient neurons; 2) examining if GEMIN5 variants cause mitochondrial dysfunctions in vivo and iPSC neurons; and 3) investigating the mechanisms of GEMIN5 mutations in mouse models. We expect to identify the molecular pathways that are perturbed in human patients.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Udai B Pandey其他文献

Udai B Pandey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Udai B Pandey', 18)}}的其他基金

Targeting epigenetic modifiers of androgen receptor activity and toxicity in SBMA
SBMA 中雄激素受体活性和毒性的表观遗传修饰因子
  • 批准号:
    9754495
  • 财政年份:
    2019
  • 资助金额:
    $ 53.97万
  • 项目类别:
Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral Sclerosis
FUS相关肌萎缩侧索硬化症的细胞和分子机制
  • 批准号:
    9303039
  • 财政年份:
    2017
  • 资助金额:
    $ 53.97万
  • 项目类别:
Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral Sclerosis
FUS相关肌萎缩侧索硬化症的细胞和分子机制
  • 批准号:
    9230443
  • 财政年份:
    2014
  • 资助金额:
    $ 53.97万
  • 项目类别:
Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral Sclerosis
FUS相关肌萎缩侧索硬化症的细胞和分子机制
  • 批准号:
    9014564
  • 财政年份:
    2014
  • 资助金额:
    $ 53.97万
  • 项目类别:
Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral Sclerosis
FUS相关肌萎缩侧索硬化症的细胞和分子机制
  • 批准号:
    8811504
  • 财政年份:
    2014
  • 资助金额:
    $ 53.97万
  • 项目类别:
Cellular and Molecular Mechanisms of FUS-related ALS/FTD
FUS相关ALS/FTD的细胞和分子机制
  • 批准号:
    10370356
  • 财政年份:
    2013
  • 资助金额:
    $ 53.97万
  • 项目类别:
Cellular and Molecular Mechanisms of FUS-related ALS/FTD
FUS相关ALS/FTD的细胞和分子机制
  • 批准号:
    9901635
  • 财政年份:
    2013
  • 资助金额:
    $ 53.97万
  • 项目类别:
Cellular and Molecular Mechanisms of FUS-related ALS/FTD
FUS相关ALS/FTD的细胞和分子机制
  • 批准号:
    9763021
  • 财政年份:
    2013
  • 资助金额:
    $ 53.97万
  • 项目类别:
Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral Sclerosis
FUS相关肌萎缩侧索硬化症的细胞和分子机制
  • 批准号:
    8529133
  • 财政年份:
    2013
  • 资助金额:
    $ 53.97万
  • 项目类别:
Cellular and Molecular Mechanisms of FUS-related ALS/FTD
FUS相关ALS/FTD的细胞和分子机制
  • 批准号:
    10582582
  • 财政年份:
    2013
  • 资助金额:
    $ 53.97万
  • 项目类别:

相似海外基金

Determining the mechanism of action of cis-acting modifiers on the age of onset of Huntington Disease
确定顺式作用修饰剂对亨廷顿病发病年龄的作用机制
  • 批准号:
    417256
  • 财政年份:
    2019
  • 资助金额:
    $ 53.97万
  • 项目类别:
    Studentship Programs
Effect of age of onset of contraception use on brain functioning.
避孕开始年龄对大脑功能的影响。
  • 批准号:
    511267-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 53.97万
  • 项目类别:
    University Undergraduate Student Research Awards
Non-random occurrence and early age of onset of diverse lymphoid cancers in families supports the existence of genetic risk factors for multiple lymphoid cancers.
家族中多种淋巴癌的非随机发生和发病年龄较早,支持多种淋巴癌存在遗传危险因素。
  • 批准号:
    347105
  • 财政年份:
    2016
  • 资助金额:
    $ 53.97万
  • 项目类别:
Polish-German Child Bilingualism: The Role of Age of Onset for Long-Term Achievement
波兰-德国儿童双语:发病年龄对长期成就的作用
  • 批准号:
    277135691
  • 财政年份:
    2015
  • 资助金额:
    $ 53.97万
  • 项目类别:
    Research Grants
Bioinformatics strategies to relate age of onset with gene-gene interaction
将发病年龄与基因间相互作用联系起来的生物信息学策略
  • 批准号:
    9097781
  • 财政年份:
    2015
  • 资助金额:
    $ 53.97万
  • 项目类别:
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration
早期 AD 发病年龄:临床异质性和网络退化
  • 批准号:
    9212684
  • 财政年份:
    2014
  • 资助金额:
    $ 53.97万
  • 项目类别:
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration
早期 AD 发病年龄:临床异质性和网络退化
  • 批准号:
    8696557
  • 财政年份:
    2014
  • 资助金额:
    $ 53.97万
  • 项目类别:
Effects of delaying age of onset of binge drinking on adolescent brain development: A proposal to add neuroimaing measures to the CO-Venture Trial.
延迟酗酒的发病年龄对青少年大脑发育的影响:在 CO-Venture 试验中添加神经影像测量的建议。
  • 批准号:
    267251
  • 财政年份:
    2012
  • 资助金额:
    $ 53.97万
  • 项目类别:
    Operating Grants
Stress Effects on Alcohol Consumption: Age of onset and genes in heavy drinkers
压力对饮酒的影响:酗酒者的发病年龄和基因
  • 批准号:
    8606722
  • 财政年份:
    2012
  • 资助金额:
    $ 53.97万
  • 项目类别:
Marijuana: Neurobiologic Correlates of Age of Onset
大麻:发病年龄的神经生物学相关性
  • 批准号:
    8644793
  • 财政年份:
    2012
  • 资助金额:
    $ 53.97万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了